Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |